Subscribe To
Ancillary cannabis stocks on the rise: keep an eye on these
As October 2023 begins, the cannabis market and marijuana stocks in the US are changing at a previously unhear...
October 5, 2023, 2:00 pm
Euro tanks after 25bp hike, lagarde goes unheard
Investors didn’t buy the rumour of a European Central Bank (ECB) rate hike but heavily sold the ECB’s intention to stop hiking the rates in the cl...
September 15, 2023, 5:45 am
Analysis-wage catch-up to prolong europe’s inflation battle
By Balazs Koranyi FRANKFURT (Reuters) – “We’ve been short-changed for too long,” is how many of Europe’s top labour unions are framing wage ...
March 10, 2023, 7:06 am
Another hawkish speech goes unheard
Another hawkish speech from the Federal Reserve (Fed) Chair Jerome Powell turned into a risk rally yesterday. Equities gained, and the bond yields fel...
February 8, 2023, 8:18 am
Making money with crypto and blockchain
Originally posted by Forex Crypto Hub Making Money with Crypto In 2023 Cryptos are certainly in the news a lot lately. It is not ...
January 7, 2023, 4:35 pm
Canaan: the unheard of computer chip stock
Canaan's expertise in ASIC chips has led to its design of a very efficient chip for Bitcoin mining and AI applications. The computer hardware and cryp...
June 14, 2022, 5:12 pm
4 clinical catalysts on tap for relmada in 2022
RLMD is set to produce results in 2022 from four clinical trials of REL-1017, its novel antidepressant. Late-stage failures of antidepressants are not...
January 28, 2022, 1:06 pm
4 clinical catalysts on tap for relmada in 2022
RLMD is set to produce results in 2022 from four clinical trials of REL-1017, its novel antidepressant. Late-stage failures of antidepressants are not...
January 28, 2022, 1:06 pm
4 clinical catalysts on tap for relmada in 2022
RLMD is set to produce results in 2022 from four clinical trials of REL-1017, its novel antidepressant. Late-stage failures of antidepressants are not...
January 28, 2022, 1:06 pm